Thanks for the feedback @joohnno. That sort of broad ranging expertise is clearly needed by SPL's BOD. The pharmaceutical world is a specialised beast and getting new products to market is massively expensive and with a very high failure rate for many reasons often outwith the company's control ( incl new competing technologies). Big Pharma has the money to push through these and you can be sure that they are daily bombarded with new product ideas from a myriad of startups, juniors, research institutes and universities. Clinical trials are expensive and often rate limiting, and have to be of excellent standard to compete for the Big Pharma dollar. This is what faces SPL's DEP product business, and so far they seem incapable of fighting through the maze to get recognised and accepted. I hope I'm wrong here.
As for the SPL7013 business... quite another beast. It seems to me that the BOD and management have just not been able to forge the right deals with suitable, committed distributors for either the Vivagel or Viraleze products, and have failed to get sufficient traction with the various regulators, possibly again through a lack of the correct skill set, experience and/or industry contacts.
Should you be successful, I think you will have your work cut out to make progress in tackling these realities. I don't think the problems are scientific per se, but rather the effective and timely interaction with other corporates, regulatory and legal entities to drive the path through to commercial success. This is where your skills could prove invaluable. I'm certainly prepared to support your effort.
- Forums
- ASX - By Stock
- SPL
- Time for action!
SPL
starpharma holdings limited
Add to My Watchlist
2.20%
!
9.3¢

Time for action!, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.3¢ |
Change
0.002(2.20%) |
Mkt cap ! $38.89M |
Open | High | Low | Value | Volume |
9.1¢ | 9.3¢ | 9.1¢ | $14.15K | 154.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 350000 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 110634 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.092 |
1 | 98913 | 0.091 |
2 | 350000 | 0.090 |
2 | 160000 | 0.089 |
2 | 300000 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 110634 | 2 |
0.095 | 58142 | 4 |
0.099 | 287150 | 11 |
0.100 | 21000 | 3 |
0.105 | 110000 | 2 |
Last trade - 16.10pm 07/07/2025 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
AGC
AUSTRALIAN GOLD AND COPPER LTD
Glen Diemar, MD
Glen Diemar
MD
SPONSORED BY The Market Online